Merck & Co. reports $16.29 billion revenue for quarter ended March 31, 2026, up 4.9%
Merck & Co. reported revenue of $16.29 billion for the quarter ended March 31, 2026, an increase of 4.9% from the same quarter a year earlier ($15.53 billion).
For the same period it posted a net loss of $4.24 billion, or $-1.72 per diluted share (2.01 a year earlier).
That is a net margin of -26%.
On Sanad's AAOIFI Standard 21 screen, Merck & Co. is currently compliant: interest-bearing debt is 15.2% of market capitalisation (limit 30%), and impure income is 0.5% of revenue (limit 5%).
Is Merck & Co. halal?
See the full AAOIFI screening of Merck & Co.
See the full AAOIFI screening of Merck & Co.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 4, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.